<PAGE>
U.S. SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 12b-25
NOTIFICATION OF LATE FILING
------------------
SEC FILE NUMBER
33205D
------------------
------------------
CUSIP NUMBER
64124R107
------------------
(Check One)
<TABLE>
<S> <C> <C> <C> <C>
{ } Form 10-K { } Form 11-K { } Form 20-F { X } Form 10-QSB { } Form N-SAR
</TABLE>
For Period Ended: September 30, 1996
Nothing in this Form shall be construed to imply that the Commission has
verified any information herein.
If the notification relates to a portion of the filing checked above, identify
the Item(s) to which the notification relates:
-------------------------------
PART I - REGISTRANT INFORMATION
- -------------------------------
Full name of Registrant NEUROCORP, LTD.
(Former Name, if Applicable)
Address of Principal Executive Office 150 WHITE PLAINS ROAD
(Street and Number)
City, State and Zip Code TARRYTOWN, NEW YORK 10591
PART II - RULES 12b-25 (b) AND (c)
- ----------------------------------
If the subject report could not be filed without reasonable effort or expense
and the Registrant seeks relief pursuant to Rule 12(b-25(b), the following
should be completed. (Check box if appropriate)
{ X } (a) The reasons described in reasonable detail in Part II of this
form could not be eliminated without unreasonable effort or
expense;
{ X } (b) The subject quarterly report on Form 10-QSB will be filed on or
before the fifth calendar day following the prescribed due date.
{ } (c) The accountant's statement or other exhibit required by Rule
12b-25(c) has been attached if applicable.
<PAGE>
PART III - NARRATIVE
- --------------------
State below in reasonable detail the reason why the Form 10-QSB could not be
filed within the prescribed time period.
Registrant is awaiting third party information so as to be
able to file a complete and accurate report.
The inability to file timely could not be eliminated by the
Registrant without unreasonable effort and expense in that
it does not have access to the needed third party
information.
PART IV - OTHER INFORMATION
- ---------------------------
(1) Name and telephone number of person to contact in regard to this
notification:
RONALD HOROWITZ 914-631-3316
--------------- --------------------
(Name) (Telephone Number)
(2) Have all other periodic reports required under section 13 or 15(d) of the
Securities Exchange Act of 1934 or section 30 of the Investment Company Act
of 1940 during the preceding 12 months or for such shorter period that the
registrant was required to file such report(s) been filed? If the answer is
no, identify report(s).
{ X } Yes { } No
(3) Is it anticipated that any significant change in results of operations from
the corresponding period(s) for the last fiscal year will be reflected by
the earnings statement to be included in the subject report or portion
thereof? If so: attach an explanation of the anticipated change, both
narratively and quantitatively, and, if appropriate, state the reasons why
a reasonable estimate of the results cannot be made.
{ X } Yes { } No
Registrant anticipates reporting a decrease in its gross
revenue and net income as compared to the corresponding
periods for 1995 but is unable to quantify or make a
reasonable estimate of such amounts until such time that the
third party information is available.
<PAGE>
NEUROCORP, LTD.
-------------------------
(Name of Registrant as specified in charter)
has caused this notification to be signed on its behalf by the undersigned
thereunto duly authorized.
Date: November 14, 1996 By: /s/ Turan M. Itil
------------------------
Dr. Turan M. Itil
Chairman
